DEBRA Research gGmbH
Overview
DEBRA Research gGmbH is a non-profit, philanthropic drug development organization that operates as the research arm of DEBRA Austria, focusing on advancing treatments and cures for Epidermolysis Bullosa (EB) through research funding and strategic investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nova Anchora | Apr 2025 | Seed | Co-investor |
| Healome Therapeutics | Jul 2026 | Seed | Co-investor |
| Dermaliq Therapeutics, Inc. | May 2025 | Strategic | Co-investor |
| Mariposa Therapeutics | Mar 2026 | Seed | Co-investor |
| Eliksa Therapeutics | Oct 2025 | Strategic | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is DEBRA Research gGmbH based?
DEBRA Research gGmbH is headquartered in Munich, Germany.
When was DEBRA Research gGmbH founded?
DEBRA Research gGmbH was founded in 2021.
How many portfolio companies does DEBRA Research gGmbH have?
DEBRA Research gGmbH has 6 portfolio companies in Caplight's dataset.
What are some companies in DEBRA Research gGmbH's portfolio?
Portfolio companies visible on Caplight include Nova Anchora, Healome Therapeutics, Dermaliq Therapeutics, Inc., Mariposa Therapeutics, Eliksa Therapeutics.
What was DEBRA Research gGmbH's most recent investment shown here?
DEBRA Research gGmbH's most recent investment in this portfolio sample was in Healome Therapeutics in 2026.
What sectors does DEBRA Research gGmbH focus on?
DEBRA Research gGmbH focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does DEBRA Research gGmbH focus on?
DEBRA Research gGmbH typically invests at the Early stage.